Updated consensus statement on biological agen... [Ann Rheum Dis. 2007] - PubMed

Save items

loading

Related citations in PubMed

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. [Ann Rheum Dis. 2006]
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.
Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Emery P, Keystone EC, Schiff MH, van Riel PL, Weinblatt ME, et al. Ann Rheum Dis. 2006 Nov; 65 Suppl 3:iii2-15.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. [Ann Rheum Dis. 2008]
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
Furst DE, Keystone EC, Kirkham B, Kavanaugh A, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Burmester GR, et al. Ann Rheum Dis. 2008 Dec; 67 Suppl 3:iii2-25.
Review [Biologicals in the treatment of rheumatic diseases]. [Dtsch Med Wochenschr. 2006]
Review [Biologicals in the treatment of rheumatic diseases].
Scherer HU, Burmester GR. Dtsch Med Wochenschr. 2006 Oct 13; 131(41):2279-85.
Review [Effectiveness and safety of biological therapy with adalimumab]. [Orv Hetil. 2009]
Review [Effectiveness and safety of biological therapy with adalimumab].
Fehér J, Lengyel G. Orv Hetil. 2009 Jun 28; 150(26):1215-22.
Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. [Am J Med. 2005]
Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, Castro MC, Olivé A, de Haro M, Portales RG, González-Mari MV, Laffón A, García-Vicuña R. Am J Med. 2005 May; 118(5):552-6.

See reviews... See all...

Cited by 15 PubMed Central articles

Rheumatoid arthritis: refractory to infliximab, a tumor necrosis factor inhibitor. [J Clin Med Res. 2011]
Rheumatoid arthritis: refractory to infliximab, a tumor necrosis factor inhibitor.
Solehan HM, Said MS, Shaharir S, Rajalingham S. J Clin Med Res. 2011 Oct; 3(5):270-4. Epub 2011 Sep 26.
Infliximab for idiopathic deep cutaneous vasculitis refractory to cyclophosphamide. [Int J Vasc Med. 2010]
Infliximab for idiopathic deep cutaneous vasculitis refractory to cyclophosphamide.
Schafranski MD, Campanari GD. Int J Vasc Med. 2010; 2010:951850. Epub 2010 Jun 27.
Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study. [Arthritis Res Ther. 2010]
Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study.
Bartelds GM, de Groot E, Nurmohamed MT, Hart MH, van Eede PH, Wijbrandts CA, Crusius JB, Dijkmans BA, Tak PP, Aarden L, et al. Arthritis Res Ther. 2010; 12(6):R221. Epub 2010 Dec 27.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Updated consensus statement on biological agents for the treatment of rheumatic ...
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Ann Rheum Dis. 2007 Nov ;66 Suppl 3:iii2-22.

PubMed
What's new in management of sexually transmitted infections? Canadian Guidelines...
What's new in management of sexually transmitted infections? Canadian Guidelines on Sexually Transmitted Infections, 2006 Edition.
Can Fam Physician. 2007 Oct ;53(10):1739-41.

PubMed
Cancer health effects of pesticides: systematic review.
Cancer health effects of pesticides: systematic review.
Can Fam Physician. 2007 Oct ;53(10):1704-11.

PubMed
Evidence-based approach to abscess management.
Evidence-based approach to abscess management.
Can Fam Physician. 2007 Oct ;53(10):1680-4.

PubMed
Case-mix adjustment in non-randomised observational evaluations: the constant ri...
Case-mix adjustment in non-randomised observational evaluations: the constant risk fallacy.
J Epidemiol Community Health. 2007 Nov ;61(11):1010-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Source

Erratum in

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 15 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information